Skip to Content

American Century Non-US IntrsVal Inv ANTUX

Medalist Rating as of | See American Century Investment Hub
  • NAV / 1-Day Return 9.32  /  +0.65 %
  • Total Assets 589.5 Mil
  • Adj. Expense Ratio
    1.190%
  • Expense Ratio 1.190%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 2.70%
  • Turnover 62%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0

Morningstar’s Analysis ANTUX

Will ANTUX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

American Century Non-US IntrsVal Inv earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ANTUX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 36.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

GSK PLC

4.95 30.4 Mil
Healthcare

SUMCO Corp

4.29 26.3 Mil
Technology

Sanofi SA

4.00 24.6 Mil
Healthcare

Roche Holding AG

3.77 23.1 Mil
Healthcare

British American Tobacco PLC

3.50 21.5 Mil
Consumer Defensive

Smurfit Kappa Group PLC

3.44 21.1 Mil
Consumer Cyclical

NN Group NV

3.32 20.4 Mil
Financial Services

Eiffage SA Bearer and / or registered shares

3.11 19.1 Mil
Industrials

Reckitt Benckiser Group PLC

3.06 18.8 Mil
Consumer Defensive

Adecco Group AG

3.03 18.6 Mil
Industrials